The ECR is coming up and we are very excited to be presenting no less than three expert lectures at the AI theater this year.
“Self-learning AI: radiologist and algorithms continuously improving each other"
Thursday at 10:30AM by Arthur Post Uiterweer, CEO Quantib
"Deep learning and radiomics in dementia and oncology”
Friday at 13:30 by prof. Wiro Niessen, CSO Quantib
“Deep learning: moving medical image interpretation beyond conventional analysis”
Saturday at 15:30 by Jorrit Glastra, CTO Quantib
And while you’re around, please stop by our booth AI-4 to try out a forerunner of our products: the oligodendroglioma challenge. Or come have a look at the new version of Quantib™ ND lobe segmentation.
Rotterdam, 23 January 2018 – Arthur Post Uiterweer, current Chief Commercial Officer of Quantib, has been named CEO of Quantib effective February 1, 2018. Rudolf Scholte, Founder and CEO, will remain on the Board of Directors to facilitate handover and support the new leadership starting the next chapter.
Quantib™ Neurodegenerative provides quantification and segmentation of MRI brain scans. It allows you to create and display self-defined views including an overlay of segmented brain tissues and CSF. You can easily download and share a comprehensive report including quantified results of several tissues and CSF.
I welcome the Quantib™ Brain software in our department because it provides robust quantitative imaging biomarkers. It facilitates a more objective way of evaluating and enables detection of subtle abnormalities.
My research focus is to develop technology to optimally exploit information contained in imaging data for improved disease diagnosis and prognosis. Quantib strives to bring this technology to the patient, enabling treatment tailored to the individual and thus realizing the enormous potential of precision medicine.
We push advanced technology forward to make sure radiologists can spend their time in the best way possible. Our engineers go to great lengths to create user-friendly solutions for challenging image analyses issues.